Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery (PREOTEST)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
The purpose of this study is to determine the predictive interest of the 6-minute stepper test in preoperative thoracic surgery. The goal is through this test to determine the risk of postoperative complications.
Condition or disease
To Evaluate the Predictive Performance of the 6-minute Stepper Test on the Risk of Complications
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
On the day of the surgical consultation, the patient is informed of the modalities of the study by the thoracic surgeon and collects his non-opposition of participation. It is also evaluated by a physiotherapist, who supervises the realization of 6MST and STST.
Non-small cell lung cancer stage I to II, justifying resection major pulmonary by VATS or RATS
Partial or total amputation localized to the lower limb;
Weight greater than 100 kg;
Orthopedic, vascular or neurological disorders leading to the incapacity of realize the TS6M;